跳至主要内容
临床试验/NCT06146530
NCT06146530招募中不适用

Cerina- Cognitive Behavioural Therapy Based Mobile Application for Managing GAD Symptoms: A Pilot Randomized Controlled Trial

Cerina Therapeutics1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2023年4月24日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
90
试验地点
1
主要终点
The Generalised Anxiety Disorder Scale-7 (GAD-7)

研究概览

简要总结

The goal of this pilot Randomized Controlled Trial is twofold: 1) To learn about the feasibility and usefulness of a mobile application for generalised anxiety symptoms (Cerina); 2) To test the preliminary effects of Cerina in reducing generalized anxiety symptoms compared to a waitlist-control group among Ulster University students presenting mild to moderate symptoms of Generalized Anxiety Disorder (GAD) symptoms. The main research questions are:

Is the Cerina app usable and feasible among Ulster University students reporting mild to moderate GAD symptoms? Is there an indication of the effectiveness of the Cerina app in reducing GAD symptoms compared to a wait-list control group among Ulster University students?

  • After the baseline assessment, eligible and consenting participants will be randomized to either intervention or to the wait-list control group.
  • Those who are allocated to the intervention group will have access to the Cerina app for 6 weeks.
  • Those who are in the wait-list control group will wait for 6 weeks until the intervention group finishes the intervention for their access.
  • The wait-list control group will have access to the services offered by the Ulster University Student Wellbeing team.
  • Participants in both groups will do mid- (at week 3 after their randomization) and post-assessment (At week 6 after their randomization).
  • All participants will also be invited to the post-assessment feedback interviews once they complete their post-assessments. The purpose is to have more in-depth information on their views of the Cerina app, the User Interface, the clinical content, the potential facilitators, and barriers to using it in daily life.

详细描述

The study is a pilot Randomised Controlled Trial (RCT) with two conditions: Treatment and a waitlist control group. Included eligible participants who have completed the baseline questionnaire will be randomized either into the treatment group in which they have access to the Cerina application for six weeks or into the wait-list control group in which they have access to the campus-based wellbeing services (i.e. routine care) until the intervention group completes Cerina. They will then receive access to Cerina. The randomization scheme will be derived using random allocation software by the Cerina technical lead who is not involved in the study.

All participants will be asked to fill in online self-report measures of anxiety, worrying, depression, and general functioning at baseline (t0), at 3 weeks (t1), and 6 weeks (t2). Additionally, semi-structured interviews will be conducted with the participants in both groups at 6 weeks (t2). The topic guide for the interview was developed by the Cerina team based on the Consolidated Framework for Implementation Research (CFIR), and it is finalized in consultation with the Principal Investigator (PI). The core topics included participants' overall experience and perceptions on the usability of the user interface of Cerina, existing pathways and barriers to using the app in daily life, the clinical utility of the application, the contexts in which the implementation of the clinical content take place and the processes of intervention delivery. The data collection will last 40 minutes, will be remote (online via the MS teams account of Ulster University), and will be facilitated by the PI and the researchers from the Ulster University. Sample size will be determined by data saturation, and sampling will be iterative to ensure theoretical saturation.

Intervention The intervention consists of 7 sessions of CBT for the treatment of anxiety and worry symptoms as part of GAD. Each session contains a range of information and tasks/exercises to help the user understand the condition of GAD, the treatment approach, and how it will apply to them. Once all sessions have been completed, the user can go back over any of the sessions. There are anxiety management exercises, which the user can go to whenever they wish. There are also a therapy reflection journal and self-care resources including further anxiety management techniques, resources, and podcasts that the user will have access to whenever they want. The names of the sessions are: Learning about GAD, dealing with worry, managing worry and anxiety, beliefs about worry, managing uncertainty, testing beliefs, review, and therapy blueprint.

Wait-list Control Condition Participants in the waiting-list control condition will have access to the campus-based well-being services offered by the Student Wellbeing team. The Wellbeing team is based on Belfast, Coleraine, and Magee campuses and provides free and confidential support and guidance to students with a broad range of issues, concerns, and challenges, to help them successfully engage in their studies. Student Wellbeing Assistants provide an initial assessment to determine a student's primary need and then Wellbeing Advisers, Student Mental Health Advisers, and Accessibility Advisers are available to provide a variety of solution-focused interventions based on that need. The Accessibility Advisers also help students with disabilities including diagnosed mental health conditions to get additional support and access funded disability support through Disabled Students' Allowance. Each campus team is led by an experienced Student Wellbeing Manager to support the advisers in the management of risk and lead to an efficient and robust response if a Clinical Incident occurs. Additionally, therapeutic counselling support is also available free to students through the external counselling provider via a dedicated 24/7 counselling helpline. The Student Wellbeing Team works closely with the counselling provider to monitor student engagement and promote the service as appropriate.

b. Statistical techniques

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Single (Investigator)

盲法说明

The randomization scheme will be derived using random allocation software by the Cerina technical lead who is not involved in the study. Randomization will take place in blocks of 6, and will take place in a 1:1 ratio. All participants will be informed about the condition they are assigned to. Please see below for the study design.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Having mild to severe self-reported anxiety symptoms. Those who score between 5 and 19 on the GAD7 questionnaire will be accepted as eligible, ,
  • 18 years of age and older
  • Enrolled as a student at Ulster University (i.e. having a student id number)
  • Fluency in English
  • Provision of an informed consent
  • Having a smartphone (i.e. Android device or iPhone).
  • Having an internet connection

排除标准

  • Having minimal anxiety symptoms as defined by a score of 5 and below on the GAD7 questionnaire
  • Scoring 19 and above on the GAD7 questionnaire
  • Having self-reported suicidal thoughts based on their scores on the Patient Health Questionnaire-9 (PHQ9).
  • Having recently (within the last 6 weeks) started taking psychotropic medication.
  • Not consenting that their contact details (name, surname, email address) will be shared with the Student Wellbeing team (see the safety section)
  • Receiving psychological treatment is not part of the exclusion criteria.

结局指标

主要结局

The Generalised Anxiety Disorder Scale-7 (GAD-7)

时间窗: baseline, week 3 and week 6

GAD-7 is a 7-item self-report scale that identifies and measures the severity of GAD. Scores range from 0 to 21, with a cut-off score of 5 distinguishing between clinical and non-clinical populations. The scale has good psychometric properties

次要结局

  • The Patient Health Questionnaire (PHQ-9)(baseline, week 3 and week 6)
  • Usability(week 3 and week 6)
  • The Work and Social Adjustment Scale (WSAS)(baseline, week 3 and week 6)
  • The Penn State Worry Questionnaire (PSWQ-PW)(baseline, week 3 and week 6)

研究者

发起方
Cerina Therapeutics
申办方类型
Industry
责任方
Principal Investigator
主要研究者

Ozlem Eylem-van Bergeijk

Post Doctoral Research Associate

Cerina Therapeutics

研究点 (1)

Loading locations...

相似试验